Heart Failure: A Companion To Braunwald’s Heart Disease (4th Edition) | KitaabNow

Heart Failure: A Companion To Braunwald’s Heart Disease (4th Edition)

  • Authors: G. Michael Felker , Douglas L. Mann
  • ISBN: 9780323609876
  • Publisher: Elsevier Science Publishing
  • Edition: 4th
  • Publication Date: April 18, 2019
  • Format: Hardback – 760 pages
  • Language: English


Up-to-date, authoritative and comprehensive, Heart Failure, 4th Edition, provides the clinically relevant information you need to effectively manage and treat patients with this complex cardiovascular problem. This fully revised companion to Braunwald’s Heart Disease helps you make the most of new drug therapies such as angiotensin receptor neprilysin inhibitors (ARNIs), recently improved implantable devices, and innovative patient management strategies. Led by internationally recognized heart failure experts Dr. G. Michael Felker and Dr. Douglas Mann, this outstanding reference gives health care providers the knowledge to improve clinical outcomes in heart failure patients.

Table of Contents
  1. Section 1 Basic Mechanisms of Heart Failure
    1. Molecular Basis for Heart Failure
    2. Cellular Basis for Heart Failure
    3. Cellular Basis for Myocardial Regeneration and Repair
    4. Myocardial Basis for Heart Failure: Role of Cardiac Interstitium
  2. Section 2 Mechanisms of Disease Progression in Heart Failure
    1. Molecular Signaling Mechanisms of the Renin-Angiotensin System in Heart Failure
    2. Adrenergic Receptor Signaling in Heart Failure
    3. Role of Innate Immunity in Heart Failure
    4. Oxidative Stress in Heart Failure
    5. Natriuretic Peptides in HF
    6. Systolic Dysfunction in Heart Failure
    7. Alterations in Ventricular Function: Diastolic Heart Failure
    8. Alterations in Ventricular Structure: Role of Left Ventricular Remodeling and Reverse Remodeling in Heart Failure
    9. Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure
    10. Alterations in the Peripheral Circulation in Heart Failure
    11. Alterations in Kidney Function Associated with Heart Failure
    12. Alterations in Skeletal Muscle in Heart Failure
    13. Alterations in Cardiac Metabolism
  3. Section 3 Etiological Basis for Heart Failure
    1. Epidemiology of Heart Failure
    2. Heart Failure as a Consequence of Ischemic Heart Diseas
    3. Heart Failure as a Consequence of Dilated Cardiomyopathy
    4. The Restrictive and Infiltrative Cardiomyopathies and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
    5. Cardiac Amyloidosis
    6. Heart Failure as a Consequence of Hypertrophic Cardiomyopathy
    7. Heart Failure as a Consequence of Genetic Cardiomyopathy
    8. Heart Failure as a Consequence of Hypertension
    9. Heart Failure as a Consequence of Valvular Heart Disease
    10. Heart Failure as a Consequence of Congenital Heart Disease
    11. Heart Failure as a Consequence of Viral and Nonviral Myocarditis
    12. Heart Failure in the Developing World
    13. Heart Failure and Human Immunodeficiency Virus
  4. Section 4 Clinical Assessment of Heart Failure
    1. Clinical Evaluation of Heart Failure
    2. Cardiac Imaging in Heart Failure
    3. Biomarkers and Precision Medicine in Heart Failure
    4. Hemodynamics in Heart Failure
  5. Section 5 Therapy for Heart Failure
    1. Disease Prevention in Heart Failure
    2. Management of Acute Decompensated Heart Failure
    3. Guidelines
    4. Contemporary Medical Therapy for Heart Failure Patients with Reduced Ejection Fraction
    5. Guidelines: Management of Heart Failure with a Reduced Ejection Fraction
    6. Management of Arrhythmias and Device Therapy in Heart Failure
    7. Guidelines
    8. Treatment of Heart Failure with Preserved Ejection Fraction
    9. Guidelines
    10. Management of Heart Failure in Special Populations: Older Patients, Women, and Racial/Ethnic Minority Groups
    11. Gene and Stem-Cell Based Therapies in Heart Failure
    12. Neuromodulation in Heart Failure
    13. Pulmonary Hypertension
    14. Cardiac Transplantation
    15. Circulatory Assist Devices in Heart Failure
    16. Cardio-Oncology and Heart Failure
    17. Disease Management and Telemedicine in Heart Failure
    18. Management of Comorbidities in Heart Failure
    19. Quality and Outcomes in Heart Failure
    20. Decision Making and Palliative Care in Advanced Heart Failure
Authors Biography

G. Michael Felker

Affiliations and Expertise

Professor of Medicine, Chief, Heart Failure Section, Division of Cardiology, Director, Clinical Research Unit, Duke Heart Center, Director of Heart Failure Research, Duke Clinical Research Institute, Durham, North Carolina

Douglas Mann

Affiliations and Expertise

Lewin Chair and Professor of Medicine and Professor of Cell Biology and Physiology at Washington University in St Louis, Missouri

Additional information
Weight1.720 kg

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

*Data Not Found